news from von
gahlen

At Von Gahlen, we would like to share an update on the enhancements in our dispenser lineup, specifically comparing the current OVDD-SA & CVDD-SA models with the newly developed OVDD-CAN & CVDD-CAN models. The latest innovations reflect our ongoing commitment to advancing safety, usability, and regulatory compliance in radiopharmaceutical solutions.

Thank you for visting us at the EANM 2024 in Hamburg.

Bob Smith (Research Engineer) and Donald Hamlin from Seattle UW Medicine, the University of Washington, visited our location in the Netherlands in November to attend the Factory Acceptance Test (FAT) of the new hot cell combined with an Ellex Solid Target delivery system, guided by Dr. Jozef Comor, Director of Elex Commerce This complete system realizes a transfer from the Ellex Solid Target delivery from a 50MeV Scanditronix Cyclotron to a 4” Customer-made hot cell for research and production.

We are delighted that we have again been recognized as an FD Gazelle. We are one of the fastest-growing companies in the East region (Netherlands) and large category.

Osman Nuri – Project Lead, and his project team from Eczacıbaşı-Monrol Nuclear Product Co. (Monrol), visited our location in the Netherlands to attend the Factory Acceptance Test (FAT) of the new n.c.a. Lutetium-177 production line.

Von Gahlen will participate in the EANM (European Association of Nuclear Medicine) in Hamburg from October 19th to 23rd, 2024. This major event in the field of nuclear medicine is a yearly highlight for us. Our sales and services teams are excited to meet existing and potential customers at our booth, which is located at the exhibition stand H22.

At Von Gahlen, we set the bar high and enforce the highest quality standards. This ensures that you can rely on our proven innovations, accurate delivery, and excellent service. Good teamwork is central to this. Lucas Lössbroek plays a crucial role in this as the Manager Engineering. Lucas: “By bringing people together and giving them the space to provide valuable input, a strong team is created. The result is that together we can tackle any challenge.”

The autoclave can be integrated in grade C / ISO 7 hot cells and in grade A / ISO 5 isolators. It is typically used for terminal sterilization of products which, because of that, do not require an aseptic environment. It could however add flexibility in a production line having an isolator that can do both aseptic production as well as products that require terminal sterilization.

Looking back on a remarkable 17-year professional journey, Gert Jan Veenstra progressed from an engineer to his current role as Technical Director at Von Gahlen. His personal career parallels the growth of Von Gahlen itself, transforming from a demand-driven entity to a company specializing in customer-focused solutions. This narrative unfolds the progression of Gert Jan and Von Gahlen’s development over the years.

At Von Gahlen, our commitment to the continual development of high-quality products hinges on effective interdepartmental collaboration. In line with this vision, we have launched the 'Product Development' department, where our R&D and Engineering teams work in synergy to ensure the future-readiness of all our solutions. R&D Engineer Eva Joosten is excited about the opportunity this new initiative brings. Eva: “R&D is very theoretical, Engineering is practical. In our team, these two aspects come together, serving as steppingstone to elevate our product range to new heights.”

(This article is available in Dutch below) On May 10 this year, Von Gahlen will celebrate its 50th anniversary. We proudly look back on our developments of the past 5 decades.

For Quality Assurance Manager Rick van Huet, “For Sure” equals providing quality. You need to be sure you are providing your customers with high-quality products. “For sure” implies that certainty.

Von Gahlen is all about long-term relationships. So, when the assembly of an installation at the customer's site is completed, it doesn't mean we're done. By providing services like remote assistance, maintenance and training, we ensure the safety of our products, the quality of the radiopharmaceuticals and an optimal user experience. But it doesn’t stop there. Our service manager Sietse Bootsma is determined to take it to the next level.

On October 11th, Von Gahlen reached an important milestone: the supercell we developed with our customer SHINE Technologies has passed the factory acceptance test! The supercell, a bank consisting of 10 hot cells, is now being prepared for shipment to SHINE's medical isotope production facility in Janesville, Wisconsin. The SHINE project is the largest project we have undertaken so far: more than eighty shipping containers will be used for shipment of the equipment.

On May 19th, our family business received a royal visitor. During a working visit, we gave Her Majesty Queen Máxima an insight into how we develop customized solutions for nuclear medicine.

(This article is available in Dutch below). It has been a year since we won the Koning Willem I Award. We are still very proud of that! Besides the fact that the award is a fantastic recognition of our work, it has also brought us a lot. In an interview with The Economic Board, our managing director Alex Duiker looks back on the entire process. He explains why other companies should join in too!

(This article is available in English below). Onze sportieve HR-manager Femke Jentink doet mee aan de Roparun, een estafetteloop door Limburg en Brabant, met start en finish in Landgraaf. Haar team ‘Liemers for Life’ loopt en fietst 325 kilometer om geld in te zamelen voor het goede doel. De opbrengst wordt door Stichting Roparun ingezet om de levenskwaliteit van kankerpatiënten te verbeteren.

(This article is only available in Dutch) ‘Innovatie is belangrijk, maar betrouwbaarheid en kwaliteit zijn het allerbelangrijkste.' Dat is de titel van het artikel in Link Magazine. In het artikel vertelt Alex Duiker over Von Gahlen. Hoe hij met zijn broer Jaap Duiker het bedrijf in 2016 overnam en hoe zij nu samen mooie stappen zetten. ‘Mijn vader heeft een sterk merk neergezet en een goede naam opgebouwd, wij willen er een nog mooier en beter bedrijf van maken’, aldus Alex Duiker.

(This article is available in Dutch below). March 2nd, 2020 was the start of a special adventure: we were nominated for the Koning Willem I Award, in the category SME! The nomination in itself was already a great honor. And when we turned out to be the winner on November 25th, 2020, we couldn't be happier! We will never forget the moment when her Majesty Queen Máxima pronounced our name during the ceremony.

(This article is only available in Dutch) Hoe blijven wij als internationale organisatie verantwoord doorwerken tijdens de coronacrisis? En hoe zorgen we dat belangrijke medische molens niet stil komen te staan? Het antwoord: dankzij lokale samenwerkingen in onze eigen regio, De Liemers. In het Liemerse magazine DUS vertellen onze managing directors Jaap en Alex Duiker uitgebreid over ondernemen in deze bijzondere tijden.

(This article is available in Dutch below). What an incredibly beautiful surprise. On Wednesday evening November 25th, we won the prestigious Koning Willem I Award in the category SMEs. In the Beurs van Berlage in Amsterdam, her majesty Queen Máxima, honorary chairman of the jury, appointed us as the winner. Our director Alex Duiker accepted the prize from DNB director Klaas Knot. It is very special to receive this great prize in times like these. We view it as a great appreciation for our worldwide performance in our market.

(This article is available in Dutch below). Great news! We have reached the final of the Koning Willem I Prijs (King William I Award), in the category SME. This makes us one of the last three out of twelve nominees. The judges particularly appreciate the development we have made in recent years. On 25 November 2020 the coveted prize will be officially awarded. We are very proud and happy with this final spot and this makes us want more!

A while ago, we proudly announced our nomination for the Koning Willem I Prijs (King William I Award). A highly prestigious distinction for Dutch entrepreneurs, or as the organizing committee calls it: The Oscars for sustainable Dutch entrepreneurship.

Von Gahlen has been active in the USA for quite a while now. Activity that can be found in Beloit (WI) for instance, where Von Gahlen increased capacity of an isotope processing facility. Or in Columbia (MO) where we expanded a cyclotron facility with a Dual Chemical Enclosure.

For Dutch See Below - The rapid spread of the coronavirus (COVID-19) has an impact on our company as well. Of course, our main priority is the health and safety of all of our employees, their families and our customers.

In 1958 the Dutch National Bank and the Ministry of Economic Affairs decided to start biannually awarding outstanding entrepreneurship in The Netherlands. This award is called the Koning Willem I Prijs (King William I Award). A highly prestigious distinction for Dutch SME’s (Small and Medium sized Enterprises). We are very proud that Von Gahlen is nominated one of the twelve contenders for the 2020 edition.

Together with Selmers and Groba we received a subsidy of €200.000 for our submission Learning on the Fly at MKB!dee*. We are very thankful for receiving this subsidy. Thanks to this subsidy we have the opportunity to develop a unique online learning platform. With this platform our employees can develop themselves personally and professionally. The construction of the platform starts January 2020.

We are proud that our solutions are part of the Amsterdam University Medical Center (Amsterdam UMC). This institute recently opened the highly anticipated Imaging Center: a global center-of-excellence in the field of biomedical imaging. It is the only place in the world where production, treatment and research are brought together in one center.

We decided that it was time for a new communication approach that clearly positions our company in the market and that reflects our company identity. This unique identity has shaped Von Gahlen since its foundation in 1973.